Postpartum hemorrhage (PPH) remains the leading cause of maternal death. PPH associated coagulopathy varies and their treatments (tranexamic acid, fibrinogen concentrates,plasma, platelets need to be targeted and administrated early. Point of care hemostasis devices are helpful to develop this strategy. Quantra® (STAGO BIOCARE) use an innovative method to detect the clot formation. Pregnancy and non-hemorrhagic postpartum reference ranges are missing. The objective of this study is to establish these norms needed to elaborate thereafter the thresholds to be targeted in PPH conditions.
Study Type
OBSERVATIONAL
Enrollment
31
Hop Jeanne de Flandre Chu Lille
Lille, France
Description of the QUANTRA® parameters range intervals before and after vaginal delivery
Time frame: At admission (= before delivery )
Description of the QUANTRA® parameters range intervals before and after vaginal delivery
Time frame: At 30 minutes +/- 10 minutes after delivery
Description of the QUANTRA® parameters range intervals before and after vaginal delivery
Time frame: At 30 up to 60 minutes after birth and placental removal.
Comparison between end of pregnancy and immediate postpartum reference values (both vaginal and caesarean deliveries)
Time frame: At 30 up to 60 minutes after birth
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.